Phase II Trial of Campto (Irinotecan CPT-II) in Pancreatic Carcinoma (CPT.GBI.619)

Project: Industry

Participants

Short titlePhase II Trial of Campto (Irinotecan CPT-II) in Pancreatic Carcinoma (CPT.GBI.619)
StatusFinished
Effective start/end date1/12/9931/05/01